Agile Therapeutics reported $-10805000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Bayer BAYN:GR EUR 2.45B 2.31B
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
JAZZ PHA JAZZ:US USD 348.04M 65.49M
Johnson & Johnson JNJ:US USD 7.81B 876M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Pain Therapeutics PTIE:US USD -21045000 1.43M
Pfizer PFE:US USD 10.52B 2.78B
Teva Pharmaceutical Industries TEVA:US USD 1.06B 31M
Therapeuticsmd TXMD:US USD -19647000 1.91M